Insights

Innovative Technology EPIX Therapeutics offers a proprietary catheter-based system with unique capabilities such as temperature sensing, low irrigation flow rates, and high-resolution electrogram attenuation. These technological advancements position the company as a leader in the minimally invasive treatment of atrial fibrillation, providing a compelling solution for healthcare providers seeking state-of-the-art ablation devices.

Market Growth Potential The global catheter ablation market for atrial fibrillation is among the fastest-growing medical device markets. This suggests significant opportunities to expand sales by targeting electrophysiology centers and cardiac clinics that are increasingly adopting advanced ablation solutions to improve patient outcomes.

Regulatory Milestones With CE Mark clearance and ongoing FDA trials for the DiamondTempTM System, EPIX is progressing toward wider commercialization. These regulatory achievements open opportunities to engage with hospitals and clinics preparing to adopt new treatments, especially in markets where the device gains approval.

Funding & Growth Having secured $45 million in recent equity funding and being backed by prominent investors like Ajax Health and NEA, the company has demonstrated strong financial backing for growth and market expansion, making it a promising partner for strategic collaborations or early adoption programs.

Strategic Acquisition Potential The company's acquisition by Medtronic highlights its strategic value and alignment with major players in the medical device industry. This signals opportunities for sales development efforts focused on integration with other major cardiovascular product portfolios or partnership negotiations to leverage existing distribution channels.

EPIX Therapeutics, Inc. Tech Stack

EPIX Therapeutics, Inc. uses 7 technology products and services including Microsoft 365, cPanel, RequireJS, and more. Explore EPIX Therapeutics, Inc.'s tech stack below.

  • Microsoft 365
    Email
  • cPanel
    Hosting Panels
  • RequireJS
    Javascript Frameworks
  • jQuery
    Javascript Libraries
  • Google Analytics
    Web Analytics
  • Apache HTTP Server
    Web Servers
  • Apache
    Web Servers

EPIX Therapeutics, Inc.'s Email Address Formats

EPIX Therapeutics, Inc. uses at least 1 format(s):
EPIX Therapeutics, Inc. Email FormatsExamplePercentage
FLast@actmed.netJDoe@actmed.net
46%
FMiddleLast@actmed.netJMichaelDoe@actmed.net
5%
FirstLast@actmed.netJohnDoe@actmed.net
3%
FLast@actmed.netJDoe@actmed.net
46%

Frequently Asked Questions

What is EPIX Therapeutics, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
EPIX Therapeutics, Inc.'s official website is actmed.net and has social profiles on LinkedIn.

What is EPIX Therapeutics, Inc.'s SIC code NAICS code?

Minus sign iconPlus sign icon
EPIX Therapeutics, Inc.'s SIC code is 3469 - Metal Stampings, Not Elsewhere Classified NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does EPIX Therapeutics, Inc. have currently?

Minus sign iconPlus sign icon
As of December 2025, EPIX Therapeutics, Inc. has approximately 51 employees across 1 continents, including North America. Key team members include Vice President Research / Development: J. K.Executive Assistant To Chief Executive Officer: M. B.Clinical Affairs Manager: E. L.. Explore EPIX Therapeutics, Inc.'s employee directory with LeadIQ.

What industry does EPIX Therapeutics, Inc. belong to?

Minus sign iconPlus sign icon
EPIX Therapeutics, Inc. operates in the Medical Equipment Manufacturing industry.

What technology does EPIX Therapeutics, Inc. use?

Minus sign iconPlus sign icon
EPIX Therapeutics, Inc.'s tech stack includes Microsoft 365cPanelRequireJSjQueryGoogle AnalyticsApache HTTP ServerApache.

What is EPIX Therapeutics, Inc.'s email format?

Minus sign iconPlus sign icon
EPIX Therapeutics, Inc.'s email format typically follows the pattern of FLast@actmed.net. Find more EPIX Therapeutics, Inc. email formats with LeadIQ.

How much funding has EPIX Therapeutics, Inc. raised to date?

Minus sign iconPlus sign icon
As of December 2025, EPIX Therapeutics, Inc. has raised $45M in funding. The last funding round occurred on May 02, 2017 for $45M.

When was EPIX Therapeutics, Inc. founded?

Minus sign iconPlus sign icon
EPIX Therapeutics, Inc. was founded in 2007.

EPIX Therapeutics, Inc.

Medical Equipment ManufacturingCalifornia, United States51-200 Employees

EPIX Therapeutics, Inc. (formerly Advanced Cardiac Therapeutics, Inc.) is a medical device company that designs and manufactures a catheter-based system for the treatment of patients with AFIB.  The Company's mission is to dramatically improve the treatment of AFIB through the introduction of products based on its proprietary catheter and generator system.  EPIX's technology is the only system in the world to leverage three unique capabilities: temperature sensing and feedback, low irrigation flow rates and high resolution electrogram attenuation.  The DiamondTempTM System is limited to investigational use in the United States. 

Founded in 2007, the company has pioneered the development of catheter ablation solutions for the treatment of atrial fibrillation and other arrhythmias.  In 2014, the company brought in industry veteran Duke Rohlen as Chairman and CEO.  Rohlen built a team that developed a novel technology, the DiamondTempTM radiofrequency ablation system, designed to treat patients with AFIB.  In late 2017, the DiamondTempTM system received CE Marking for the device, and FDA approval of an investigational device evaluation application (IDE) to commence a 480-subject, multicenter, global, pivotal trial (Diamond-AF) to treat patients with paroxysmal AFIB.  The company expects to complete the enrollment of this IDE study the end of 2018.

The DiamondTemp™ is a medical device and is subject to applicable country and/or regional regulations.

Atrial fibrillation is a condition in which the heart beats irregularly due to improper electrical impulses and is one of the most prevalent heart diseases globally, currently affecting an estimated six million people in the U.S. alone. The irregular heart beat can lead to increased risk of stroke and significant diminishment of quality of life for affected individuals.  Catheter ablation has been demonstrated to be a safe, effective, and economic treatment for atrial fibrillation.  The catheter ablation market is one of the fastest growing medical device markets today.

Section iconCompany Overview

Website
actmed.net
SIC Code
3469 - Metal Stampings, Not Elsewhere Classified
NAICS Code
3391 - Medical Equipment and Supplies Manufacturing
Founded
2007
Employees
51-200

Section iconFunding & Financials

  • $45M

    EPIX Therapeutics, Inc. has raised a total of $45M of funding over 6 rounds. Their latest funding round was raised on May 02, 2017 in the amount of $45M.

  • $1M

    EPIX Therapeutics, Inc.'s revenue is estimated to be in the range of $1M

Section iconFunding & Financials

  • $45M

    EPIX Therapeutics, Inc. has raised a total of $45M of funding over 6 rounds. Their latest funding round was raised on May 02, 2017 in the amount of $45M.

  • $1M

    EPIX Therapeutics, Inc.'s revenue is estimated to be in the range of $1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.